Until recently, Ozempic was a little-known diabetes medication. But, when mainstream media outlets and even medical schools began touting the drug’s weight loss benefits, Ozempic was quickly thrust into the national...more
Years of Inspections, Reports, Letters from FDA Went Unheeded -
MasterPharm Compounding Pharmacy in South Richmond Hill, N.Y., has recalled a “bad batch” of a drug called Finasteride Plus, known as FinPlus, that aids in...more
The next hearing session of the United States Judicial Panel on Multidistrict Litigation (“JPML”) is scheduled for January 31, 2019 in Miami, Florida. Six matters are set for oral argument to consider motions to transfer each...more
1/30/2019
/ Antitrust Litigation ,
Antitrust Violations ,
Case Consolidation ,
Class Action ,
Contamination ,
Cybersecurity ,
Data Breach ,
Data Security ,
FDCPA ,
Franchise Agreements ,
Franchisee ,
Generic Drugs ,
Hackers ,
Motion To Centralize ,
Motion to Transfer ,
No-Poaching ,
Oral Argument ,
Personally Identifiable Information ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Product Recalls ,
Putative Class Actions ,
Sherman Act ,
Wage and Hour
One trillion dollars. That’s how much the country spent on the opioid epidemic between 2001 and 2017, according to a report released by the nonprofit institute Altarum, a consulting group focused on improving public...more